ustekinumab
janssen
['ustekinumab']
 hi peter, not sure i understand the question. risk of tb depends on how much m.tuberculosis is circulating and whether patients are screened / offered tb preventive therapy. looking at the slides, do i understand that the ustekinumab group had less tb than the placebo group?
Professor of Medicine @McGillU. 
Director, Infectious Diseases, McGill. 
Director, MI4.
Pathogenesis and epidemiology of TB.